Endocrine Diseases


Sitagliptin Tied to Improved Outcomes among Diabetics with COVID-19

October 01, 2020

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

Generic Levothyroxine as Effective as Brand Name for Achieving Thyrotropin Goals

October 01, 2020

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

Exposure to Diabetes in the Womb Could Increase Heart Disease Risk

September 30, 2020

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

Increased Number of Menopause Symptoms Tied to Increased Cardiovascular Disease Risk

September 29, 2020

An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

September 25, 2020

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Metformin Could Slow Cognitive Decline, Reduce Dementia Incidence in Diabetics

September 24, 2020

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

September 23, 2020

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

September 23, 2020

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries

September 22, 2020

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes

September 22, 2020

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

Synthetic Medication, Desiccated Thyroid Similar in Effectiveness for Hypothyroidism

September 21, 2020

Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.

Study Finds Thyroid Inflammation Tied to Anxiety Disorders

September 19, 2020

A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.

Pediatric Asthma Treatment Could Increase Risk of Diabetes, Other Conditions

September 18, 2020

New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.

Feelings of Loneliness in Older Adults Tied to Increase Risk of New-Onset Diabetes

September 16, 2020

Analysis of data from a European aging study suggests feeling lonely was linked to an increased risk of developing diabetes in older adults.

Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020

September 01, 2020

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

Exposure to Endocrine-Disrupting Chemicals Linked to ADHD in Adolescents

August 29, 2020

An analysis of data from the New Bedford Cohort suggests exposure to endocrine-disrupting chemicals could increased risk of ADHD in adolescents.

Long-Acting GLP-1 RAs More Effective than Short-Acting for Diabetes Management

August 28, 2020

A meta-analysis examines the differences in HbA1c management, weight loss, and other factors associated with long- versus short-acting GLP-1 receptor agonists.

Artificial Pancreas Proven Safe and Effective in Diabetics 6 Years and Older

August 27, 2020

A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age.

Weight Loss, Not Surgery, Responsible for Metabolic Benefits Following Gastric Bypass

August 20, 2020

A study comparing 22 patients is offering a detailed overview of the effects of weight loss as a result of gastric bypass surgery and diet alone in obese patients.

Nationwide Analysis Details Risk of COVID-19-Related Death in Type 1, Type 2 Diabetics

August 16, 2020

An analysis of data from England details the increased odds of mortality associated with type 1 and type 2 diabetes in COVID-19 patients.